Smartwatch tool predicts Parkinson’s disease up to 7 years before onset
By
Aaron Dorman
Jul 11, 2023
Data from a smart watch could help predict Parkinson’s disease up to seven years before symptoms begin occurring, a new study shows.
FDA fast-tracks Alzheimer’s drug
By
Lois A. Bowers
Aug 22, 2016
The FDA has granted fast-track status to a drug that is in clinical trials for Alzheimer’s disease, according to the developers of the medication.
Review of light therapy studies confirms its potential for helping Alzheimer’s patients
By
Aaron Dorman
Dec 08, 2023
A review of recent literature on light therapy reiterated that it improved sleep and behavior issues for those living with Alzheimer’s disease.
Alzheimer’s in danger of straining public funding: report
By
Lois A. Bowers
Oct 05, 2017
Social and demographic trends combined with an expected increase in the incidence of Alzheimer’s diseases due to the growing size of the aging population are in danger of colliding to strain local,...
App that completes sentences for dementia patients a big winner
By
Aaron Dorman
Jun 21, 2023
An Amicus Brain Innovations virtual speech assistant will utilize artificial intelligence to echo a “modified,” more cohesive version of a users’ impaired speech.
Sensitivity study shines a light on how Alzheimer’s patients could benefit from carefully managed sleep...
By
Aaron Dorman
Aug 01, 2023
Light therapy could be a vital tool for people living with Alzheimer’s to manage or slow the disease, a new study shows.
Report: Alzheimer’s is costliest disease in United States
By
Lois A. Bowers
Apr 04, 2016
A new report from the Alzheimer’s Association provides updated information on the current and predicted prevalence and cost of Alzheimer’s disease.
Straight from the gut: AI helps researchers confirm Alzheimer’s link
By
John O'Connor
Apr 24, 2024
Cleveland Clinic researchers are using artificial intelligence to confirm the link between the gut microbiome and Alzheimer’s disease.
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
More frequent hearing aid use could help stave off dementia, experts suggest
By
Aaron Dorman
Jan 08, 2024
Newly available non-prescription hearing aid use could have major overall health benefits and reduce the risk of dementia, experts say.